77 related articles for article (PubMed ID: 15331151)
21. Astrocyte dysfunction and neurovascular impairment in neurological disorders: Correlation or causation?
McConnell HL; Li Z; Woltjer RL; Mishra A
Neurochem Int; 2019 Sep; 128():70-84. PubMed ID: 30986503
[TBL] [Abstract][Full Text] [Related]
22. TGF-β1 Restores Hippocampal Synaptic Plasticity and Memory in Alzheimer Model via the PI3K/Akt/Wnt/β-Catenin Signaling Pathway.
Hu Y; Chen W; Wu L; Jiang L; Liang N; Tan L; Liang M; Tang N
J Mol Neurosci; 2019 Jan; 67(1):142-149. PubMed ID: 30539409
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
Front Immunol; 2018; 9():2122. PubMed ID: 30283455
[TBL] [Abstract][Full Text] [Related]
24. Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways.
Zeng L; Zhang D; McLoughlin HS; Zalon AJ; Aravind L; Paulson HL
PLoS One; 2018; 13(9):e0204438. PubMed ID: 30231063
[TBL] [Abstract][Full Text] [Related]
25. Targeting Neuroinflammation to Treat Alzheimer's Disease.
Ardura-Fabregat A; Boddeke EWGM; Boza-Serrano A; Brioschi S; Castro-Gomez S; Ceyzériat K; Dansokho C; Dierkes T; Gelders G; Heneka MT; Hoeijmakers L; Hoffmann A; Iaccarino L; Jahnert S; Kuhbandner K; Landreth G; Lonnemann N; Löschmann PA; McManus RM; Paulus A; Reemst K; Sanchez-Caro JM; Tiberi A; Van der Perren A; Vautheny A; Venegas C; Webers A; Weydt P; Wijasa TS; Xiang X; Yang Y
CNS Drugs; 2017 Dec; 31(12):1057-1082. PubMed ID: 29260466
[TBL] [Abstract][Full Text] [Related]
26. Microglial Activation Results in Inhibition of TGF-β-Regulated Gene Expression.
Affram KO; Mitchell K; Symes AJ
J Mol Neurosci; 2017 Dec; 63(3-4):308-319. PubMed ID: 28983846
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the transforming growth factor-β/SMAD cascade mitigates the anti-neurogenic effects of the carbamate pesticide carbofuran.
Seth B; Yadav A; Agarwal S; Tiwari SK; Chaturvedi RK
J Biol Chem; 2017 Nov; 292(47):19423-19440. PubMed ID: 28982980
[TBL] [Abstract][Full Text] [Related]
28. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.
Takeuchi M; Takino JI; Sakasai-Sakai A; Takata T; Tsutsumi M
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28632197
[TBL] [Abstract][Full Text] [Related]
29. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.
Takeuchi M
Diagnostics (Basel); 2016 Jun; 6(2):. PubMed ID: 27338481
[TBL] [Abstract][Full Text] [Related]
30. Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.
Ring KL; An MC; Zhang N; O'Brien RN; Ramos EM; Gao F; Atwood R; Bailus BJ; Melov S; Mooney SD; Coppola G; Ellerby LM
Stem Cell Reports; 2015 Dec; 5(6):1023-1038. PubMed ID: 26651603
[TBL] [Abstract][Full Text] [Related]
31. Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells.
Koriyama Y; Furukawa A; Muramatsu M; Takino J; Takeuchi M
Sci Rep; 2015 Aug; 5():13313. PubMed ID: 26304819
[TBL] [Abstract][Full Text] [Related]
32. Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?
Fan CK; Holland CV; Loxton K; Barghouth U
Clin Microbiol Rev; 2015 Jul; 28(3):663-86. PubMed ID: 26062575
[TBL] [Abstract][Full Text] [Related]
33. TGF-β1 protection against Aβ1-42-induced neuroinflammation and neurodegeneration in rats.
Shen WX; Chen JH; Lu JH; Peng YP; Qiu YH
Int J Mol Sci; 2014 Dec; 15(12):22092-108. PubMed ID: 25470026
[TBL] [Abstract][Full Text] [Related]
34. Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes.
Ahrén B
World J Diabetes; 2014 Feb; 5(1):40-51. PubMed ID: 24567800
[TBL] [Abstract][Full Text] [Related]
35. Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.
Brosseron F; Krauthausen M; Kummer M; Heneka MT
Mol Neurobiol; 2014 Oct; 50(2):534-44. PubMed ID: 24567119
[TBL] [Abstract][Full Text] [Related]
36. Age-dependent changes on TGFβ1 Smad3 pathway modify the pattern of microglial cell activation.
Tichauer JE; Flores B; Soler B; Eugenín-von Bernhardi L; Ramírez G; von Bernhardi R
Brain Behav Immun; 2014 Mar; 37():187-96. PubMed ID: 24380849
[TBL] [Abstract][Full Text] [Related]
37. Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.
Hampel H; Lista S
J Nutr Health Aging; 2013 Jan; 17(1):54-63. PubMed ID: 23299381
[TBL] [Abstract][Full Text] [Related]
38. Fluid biomarkers in Alzheimer disease.
Blennow K; Zetterberg H; Fagan AM
Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a006221. PubMed ID: 22951438
[TBL] [Abstract][Full Text] [Related]
39. Astrocytes as a source for extracellular matrix molecules and cytokines.
Wiese S; Karus M; Faissner A
Front Pharmacol; 2012; 3():120. PubMed ID: 22740833
[TBL] [Abstract][Full Text] [Related]
40. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
de la Monte SM
Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
